Agreement - June 9, 2026
AlzeCure Pharma enters collaboration and out-licensing agreement with Lilly
AlzeCure Pharma has entered into a collaboration and out-licensing agreement with the pharmaceutical company Eli Lilly and Company regarding the global rights to the Alzheimer’s project Alzstatin ACD680.
Collaboration - June 8, 2026
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China
Moberg Pharma has entered into a license agreement with Karo Healthcare regarding the commercialization of the nail fungus drug MOB-015 (Terclara) in China through the rapidly growing cross-border e-commerce channel.
Clinical Trials - June 8, 2026
Pharmability submits clinical trial application for first-in-human Phase Ib study
Pharmability has announced the submission of a Clinical Trial Application (CTA) for TIR-C, the company's lead drug candidate for atopic dermatitis (eczema).
Pharma Business - June 5, 2026
Diamyd Medical provides business update
As part of an ongoing strategic review, the company has received several proposals from external parties, including formal non-binding Letters of Intent, as well as invitations to invest into various business opportunities, it states.
Pharma Business - June 3, 2026
Herantis reports positive FDA feedback
Herantis Pharma provides an update on preparations for the Phase 2a proof-of-concept efficacy study of HER-096, its lead candidate for the treatment of Parkinson's disease.
Financing - June 3, 2026
Stayble Therapeutics files for bankruptcy
Stayble Therapeutics has announced that its Board of Directors has resolved to file for bankruptcy, with the application to be submitted to the Gothenburg District Court.
